GT Biopharma (GTBP) Financials: Revenue & Earnings
$7.06M
Market Cap
-0.05
P/E
22.38
Forward P/E
53
Score
GTBP price $5.59 +0.01 +0.27%
Stocklytics score rationale: value 59, quality 51, growth 50.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GT Biopharma, Inc. is a biopharmaceutical company in the clinical development phase, dedicated to discovering and bringing to market novel immuno-oncology treatments. Their innovative approach centers on a proprietary technology platform called Tri-specific Killer Engager (TriKE) fusion proteins, which are designed to harness the body's immune cells. Central to their pipeline is GTB-3550, a single-chain tri-specific…
GTBP fair value $9.68. Price $5.59. Price is 42% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-13 | — | -2.50 | — | — |
| 2026-08-14 | -3.00 | -2.00 | — | — |
| 2026-05-21 | -0.11 | -2.00 | — | — |
| 2026-03-02 | -55.50 | -5.50 | — | — |
| 2025-11-13 | -0.83 | -9.50 | — | — |
| 2025-08-13 | -0.55 | -17.00 | — | — |
| 2025-05-21 | -0.33 | -16.00 | — | — |
| 2025-03-25 | -1.67 | -38.75 | — | — |
| 2024-11-14 | -1.53 | -2.70 | — | — |
| 2024-08-16 | -54.25 | -67.50 | — | — |
| 2024-05-15 | -41.00 | -67.50 | — | — |
| 2024-03-28 | -54.75 | -67.50 | — | — |
| 2023-11-01 | -1.50 | -2.50 | — | — |
| 2023-08-10 | -41.26 | -2.50 | — | — |
| 2023-05-15 | -5.25 | -4.00 | — | — |
| 2023-03-30 | -4.50 | -4.25 | — | — |
| 2022-10-31 | -5.50 | -2.75 | — | — |
| 2022-08-11 | -2.50 | -4.25 | — | — |
| 2022-05-16 | -4.25 | -7.75 | — | — |
| 2022-03-28 | -13.00 | -5.25 | — | — |
| 2021-11-10 | -4.75 | -5.25 | — | — |
| 2021-08-23 | -3.25 | -7.00 | — | — |
| 2021-05-17 | -45.75 | -6.00 | — | — |
| 2021-04-16 | -84.75 | -1.00 | — | — |
| 2020-11-13 | -20.43 | — | — | — |
| 2020-08-14 | -40.86 | — | — | — |
| 2020-05-15 | -10.21 | — | — | — |
| 2020-03-27 | -9.25 | — | — | — |
| 2019-11-14 | -219.61 | — | — | — |
| 2019-08-14 | -25.54 | — | — | — |
| 2019-05-15 | -45.96 | — | — | — |
| 2019-03-29 | -35.75 | — | — | — |
| 2018-11-15 | -71.50 | — | — | — |
| 2018-08-14 | -91.93 | — | — | — |
| 2018-05-15 | -102.14 | — | — | — |
| 2018-03-01 | -51.00 | — | — | — |
| 2017-11-14 | -4,208.29 | — | — | — |
| 2017-08-11 | -63,283.75 | — | — | — |
| 2017-04-28 | -157,472.00 | — | — | — |
| 2017-03-31 | -6,267.75 | — | — | — |
Yield 0.00%. Payout ratio —. Frequency —.
Safety score 24/100 · At risk. Payout ratio is not reported, so this part stays neutral. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2025-09-04 | Mun-Gavin David C. | Buy | 31.25K | $1.33 | 41.56K |
| 2025-09-04 | Breen Michael Martin | Buy | 100.00K | $1.33 | 133.00K |
| 2025-09-04 | URBAN ALAN LOUIS | Buy | 50.00K | $1.33 | 66.50K |
| 2025-09-04 | CASAMENTO CHARLES J | Buy | 62.50K | $1.33 | 83.12K |
| 2025-09-04 | Kramer Hilary | Buy | 31.25K | $1.33 | 41.56K |
| 2025-06-10 | Mun-Gavin David C. | Other | 0 | — | — |
| 2025-05-08 | Ritter Andrew J | Other | 0 | — | — |
| 2025-05-07 | Kramer Hilary | Other | 0 | — | — |
| 2024-10-17 | URBAN ALAN LOUIS | Buy | 23.34K | $2.11 | 49.24K |
| 2024-06-03 | URBAN ALAN LOUIS | Other | 0 | — | — |
| 2023-08-11 | Breen Michael Martin | Buy | 200.00K | $0.29 | 57.40K |
| 2023-08-11 | Ohri Manu | Buy | 200.00K | $0.29 | 57.40K |
| 2023-08-11 | Ohri Manu | Buy | 200.00K | $0.29 | 57.40K |
| 2023-08-11 | Ohri Manu | Sell | 200.00K | $0.29 | 57.40K |
| 2023-06-16 | CASAMENTO CHARLES J | Buy | 500.00K | $0.35 | 175.00K |
| 2023-05-01 | CASAMENTO CHARLES J | Other | 0 | — | — |
| 2023-04-11 | Breen Michael Martin | Buy | 50.00K | $0.50 | 25.00K |
| 2023-04-06 | Ohri Manu | Buy | 50.00K | $0.50 | 25.00K |
| 2023-01-27 | Breen Michael Martin | Buy | 500.00K | $0.84 | 418.50K |
| 2023-01-27 | SHROTRIYA RAJESH C MD | Buy | 500.00K | $0.84 | 418.50K |
| 2023-01-27 | Ohri Manu | Buy | 500.00K | $0.84 | 418.50K |
| 2023-01-27 | Wendel Bruce | Buy | 500.00K | $0.84 | 418.50K |
| 2022-07-15 | Breen Michael Martin | Buy | 50.00K | — | — |
| 2022-07-15 | SHROTRIYA RAJESH C MD | Buy | 50.00K | — | — |
| 2022-07-15 | URBAN ALAN LOUIS | Buy | 50.00K | $2.48 | 124.00K |
| 2022-07-15 | URBAN ALAN LOUIS | Buy | 50.00K | — | — |
| 2022-07-15 | Berk Gregory | Buy | 50.00K | $2.48 | 124.00K |
| 2022-07-15 | Berk Gregory | Buy | 50.00K | — | — |
| 2022-07-15 | Ohri Manu | Buy | 200.00K | — | — |
| 2022-07-15 | Ohri Manu | Sell | 100.00K | — | — |
| 2022-07-15 | Wendel Bruce | Buy | 50.00K | — | — |
| 2022-06-09 | URBAN ALAN LOUIS | Other | 0 | — | — |
| 2022-02-14 | Ohri Manu | Other | 0 | — | — |
| 2021-12-31 | Choy Gavin | Buy | 227.50K | $3.05 | 693.88K |
| 2021-11-28 | Choy Gavin | Other | 0 | — | — |
| 2021-02-25 | Breen Michael Martin | Buy | 9.86K | $3.40 | 33.52K |
| 2021-02-25 | Breen Michael Martin | Buy | 40.24K | $3.40 | 136.83K |
| 2021-02-25 | Breen Michael Martin | Sell | 30.00K | $3.40 | 102.00K |
| 2021-02-16 | Berk Gregory | Buy | 278.06K | — | — |
| 2021-02-16 | Berk Gregory | Buy | 50.00K | $6.33 | 316.50K |
| 2021-02-16 | SHROTRIYA RAJESH C MD | Buy | 50.00K | $6.33 | 316.50K |
| 2021-02-16 | Breen Michael Martin | Buy | 278.06K | — | — |
| 2021-02-16 | Breen Michael Martin | Buy | 50.00K | $6.33 | 316.50K |
| 2021-02-16 | Wendel Bruce | Buy | 347.57K | — | — |
| 2021-02-16 | Wendel Bruce | Buy | 50.00K | $6.33 | 316.50K |
| 2021-01-13 | SHROTRIYA RAJESH C MD | Other | 0 | — | — |
| 2020-12-22 | Wendel Bruce | Buy | 441 | $8.73 | 3.85K |
| 2020-12-22 | Wendel Bruce | Buy | 1.37K | $8.87 | 12.19K |
| 2020-12-22 | Weldon Steven W | Sell | 47.98K | $0.40 | 19.19K |
| 2020-12-21 | Weldon Steven W | Sell | 50.00K | $0.30 | 15.00K |
| 2020-12-21 | Weldon Steven W | Sell | 50.00K | $0.33 | 16.50K |
| 2020-12-21 | Weldon Steven W | Sell | 35.72K | $0.34 | 12.15K |
| 2020-12-18 | Weldon Steven W | Sell | 50.00K | $0.30 | 15.00K |
| 2020-12-17 | Weldon Steven W | Sell | 50.00K | $0.30 | 15.00K |
| 2020-12-17 | Weldon Steven W | Sell | 50.00K | $0.31 | 15.50K |
| 2020-12-16 | Weldon Steven W | Sell | 50.00K | $0.30 | 15.00K |
| 2020-12-15 | Weldon Steven W | Sell | 50.00K | $0.30 | 15.00K |
| 2020-12-15 | Weldon Steven W | Sell | 50.00K | $0.30 | 15.00K |
| 2020-12-15 | Weldon Steven W | Sell | 50.00K | $0.32 | 16.00K |
| 2020-12-14 | Weldon Steven W | Sell | 50.00K | $0.28 | 14.00K |
| 2020-12-14 | Weldon Steven W | Sell | 50.00K | $0.29 | 14.50K |
| 2020-12-14 | Weldon Steven W | Sell | 46.30K | $0.29 | 13.43K |
| 2020-12-11 | Weldon Steven W | Sell | 50.00K | $0.25 | 12.50K |
| 2020-12-11 | Weldon Steven W | Sell | 50.00K | $0.26 | 13.00K |
| 2020-11-16 | Wendel Bruce | Buy | 3.27K | $3.14 | 10.26K |
| 2020-11-11 | Berk Gregory | Other | 0 | — | — |
| 2020-11-11 | Wendel Bruce | Other | 0 | — | — |
| 2020-06-23 | Breen Michael Martin | Sell | 0 | $3.40 | 0 |
| 2020-06-02 | Cataldo Tony | Sell | 4.23M | $0.00 | 4.23K |
| 2020-05-13 | Weldon Steven W | Sell | 2.27M | $0.00 | 2.27K |
| 2019-08-14 | Cataldo Tony | Buy | 7.00M | — | — |
| 2019-08-14 | Weldon Steven W | Buy | 4.50M | — | — |
| 2019-02-06 | Cataldo Tony | Sell | 800.00K | $0.00 | 800 |
| 2019-02-01 | Urbanski Raymond W. | Sell | 176.98K | $0.00 | 177 |
| 2017-11-16 | Cross Shawn | Other | 0 | — | — |
| 2017-11-02 | Cataldo Tony | Sell | 200.00K | — | — |
| 2017-11-02 | Cataldo Tony | Sell | 100.00K | — | — |
| 2017-11-02 | Cataldo Tony | Sell | 3.00M | — | — |
| 2017-09-01 | Cataldo Tony | Buy | 5.13M | — | — |
| 2017-09-01 | Urbanski Raymond W. | Sell | 0 | — | — |
| 2017-09-01 | Clarence-Smith Kathleen | Sell | 0 | — | — |
| 2017-09-01 | Weldon Steven W | Buy | 2.57M | — | — |
| 2017-09-01 | Silverman Mark J | Sell | 0 | — | — |
| 2016-04-05 | BRISTOL INVESTMENT FUND LTD | Buy | 250.00K | — | — |
| 2016-04-04 | BRISTOL INVESTMENT FUND LTD | Sell | 675.00K | $303,750.00 | 205.03B |
| 2016-02-09 | BRISTOL INVESTMENT FUND LTD | Sell | 0 | — | — |
| 2016-01-25 | Cataldo Tony | Sell | 0 | — | — |
| 2016-01-25 | Weldon Steven W | Sell | 0 | — | — |
| 2016-01-13 | BRISTOL INVESTMENT FUND LTD | Sell | 0 | — | — |
| 2016-01-13 | BRISTOL INVESTMENT FUND LTD | Sell | 3.91M | $1.25 | 4.89M |
| 2012-03-01 | Saloff David | Buy | 26.33M | $0.04 | 1.05M |
| 2011-08-31 | Saloff David | Buy | 538.71K | $0.05 | 28.82K |
| 2011-06-30 | Saloff David | Sell | 777.78K | $0.09 | 70.00K |
| 2011-06-27 | Eaton Kenneth Haynes | Sell | 250.00K | $0.09 | 22.50K |
| 2011-05-20 | DUBE ANSHUMAN | Buy | 0 | $0.10 | 0 |
| 2010-12-27 | DUBE ANSHUMAN | Sell | 360.10K | $0.13 | 47.21K |
| 2010-12-27 | Theorem Group, LLC | Sell | 360.10K | $0.13 | 47.21K |
| 2010-12-23 | DUBE ANSHUMAN | Sell | 700.00K | $0.05 | 35.00K |
| 2010-12-23 | DUBE ANSHUMAN | Buy | 700.00K | $0.05 | 35.00K |
| 2010-12-23 | DUBE ANSHUMAN | Sell | 339.90K | $0.13 | 44.19K |
Latest filed quarter: Q2 2026.
Institutions holding: 58, holders +19 vs prior quarter. Ownership 5.42%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 376.40K | -75.48K | -16.70% | 184.44K |
| GEODE CAPITAL MANAGEMENT, LLC | 266.79K | -27.67K | -9.40% | 130.65K |
| VANGUARD FIDUCIARY TRUST CO | 225.94K | 0 | 0.00% | 110.71K |
| HRT FINANCIAL LP | 107.14K | 107.14K | New | 52.00K |
| EVERHART FINANCIAL GROUP, INC. | 100.00K | 100.00K | New | 48.97K |
| ARAX ADVISORY PARTNERS | 93.63K | 0 | 0.00% | 45.85K |
| OPAL WEALTH ADVISORS, LLC | 81.81K | 81.81K | New | 40.06K |
| NORTHERN TRUST CORP | 75.46K | 75.46K | New | 36.95K |
| ALONGSIDE, LLC | 64.00K | 64.00K | New | 31.34K |
| 49 WEALTH MANAGEMENT, LLC | 64.00K | 64.00K | New | 31.34K |
| CETERA INVESTMENT ADVISERS | 55.94K | 55.94K | New | 27.39K |
| SEACREST WEALTH MANAGEMENT, LLC | 50.10K | 100 | +0.20% | 24.53K |
| KITCHING PARTNERS, LLC | 50.00K | 50.00K | New | 24.48K |
| PNC FINANCIAL SERVICES GROUP, INC. | 40.00K | 40.00K | New | 19.60K |
| OSAIC HOLDINGS, INC. | 38.50K | 17.50K | +83.33% | 18.86K |
| LPL FINANCIAL LLC | 36.38K | 6.00K | +19.74% | 17.82K |
| MORGAN STANLEY | 22.57K | 5.97K | +35.99% | 11.05K |
| KEEL POINT, LLC | 20.77K | 0 | 0.00% | 10.17K |
| INTEGRATED WEALTH CONCEPTS LLC | 20.01K | 0 | 0.00% | 9.80K |
| PRIVATE WEALTH MANAGEMENT GROUP, LLC | 20.00K | 0 | 0.00% | 9.79K |
| CORIENT PRIVATE WEALTH LP | 20.00K | 20.00K | New | 9.79K |
| SAGESPRING WEALTH PARTNERS, LLC | 20.00K | 20.00K | New | 9.79K |
| STONEX GROUP INC. | 23.26K | 8.50K | +57.62% | 8.67K |
| CAITLIN JOHN, LLC | 16.50K | 0 | 0.00% | 8.08K |
| COSTON, MCISAAC & PARTNERS | 17.09K | 0 | 0.00% | 8.00K |
GT Biopharma, Inc. (GTBP) trades at $5.59, with a market cap of $7.06M and a trailing P/E of -0.05. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Insights · Dividends · Forecast · Financials · Learn
$7.06M
Market Cap
-0.05
P/E
22.38
Forward P/E
53
Score